There’s a Desperate Need for Better Mental Health Care

Small Cap Biotech Stocks

Mental health just in the U.S. in on the decline, with startling statistics.

For example, “From 2019 to 2020 symptoms of anxiety disorders tripled and depressive disorders quadrupled. One in 10 American adults reported an increase in substance use in 2020 because of the pandemic and the number of people reporting serious consideration of suicide has doubled since 2018,” reports

Racing to help are companies such as AI/ML Innovations (CSE:AIML)(OTC:AIMLF), Fobi AI Inc. (TSXV:FOBI)(OTC:FOBIF), Nubeva Technologies Ltd. (TSXV:NBVA)(OTC:NBVAF), VSBLTY Groupe Technologies Corp. (CSE:VSBY)(OTC:VSBGF), and Reliq Health Technologies Inc. (TSXV:RHT)(OTC:RQHTF).

In addition, according to Scientific American, “Prior to the pandemic, mental health conditions were a leading cause of disability worldwide. Rates of diagnosis have been rising across all age demographics for years, costing the global economy an estimated $1 trillion annually. And the impact on the young has been particularly devastating. Suicide is now second only to accidents in deaths among teenagers. Since the beginning of 2020, the situation has deteriorated further: the U.S. has seen a large increase in adults reporting symptoms of anxiety and depression, and the impacts on children will likely reverberate for years to come.”